Healthcare investors are prepared to shell out $152 million to bring a pricey high-tech cancer radiation therapy to Connecticut, but getting commercial health insurers to cover the treatments may not be easy.
Proton beam radiation therapy delivers high doses of radiation to targeted areas of the body, sparing healthy tissue and vital organs around a tumor.